References
- Olivier D, Lubman DI, Fraser R. Tobacco smoking within psychiatry inpatient settings: a biopsychosocial perspective. Aust N Z J Psychiatry 2007; 41: 572–580
- Lubman DI, Sundram S. Substance use in patients with schizophrenia: a primary care guide. Med J Aust 2003; 178: S71–S75
- Chen J, Millar WJ. Age of smoking initiation: implications for quitting. Health Rep 1998; 9: 39–46
- Jorm AF, Wright A, Morgan AJ. Beliefs about appropriate first aid for young people with mental disorders: findings from an Australian national survey of youth and parents. Early Interv Psychiatry 2007; 1: 61–70
- Mathers M, Toumbourou JW, Catalano RF, et al. Consequences of youth tobacco use: a review of prospective behavioural studies. Addiction 2006; 101: 948–958
- McKenna K, Koren G, Tetelbaum M, et al. Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study. J Clin Psychiatry 2005; 66: 444–449
- Yaeger D, Smith HG, Altshuler LL. Atypical antipsychotics in the treatement of schizophrenia during pregnancy and the postpartum. Am J Psychiatry 2006; 163: 2064–2070
- Diav-Citrin O, Shechtman S, Ornoy S, et al. Safety of haloperidol and penfluridol in pregnancy: a multicenter, prospective, controlled study. J Clin Psychiatry 2005; 66: 317–322